✦ LIBER ✦

PAYER PERSPECTIVES ON DRUG PRICING, COVERAGE, AND REIMBURSEMENT IN OPHTHALMOLOGIC ORPHAN CONDITION IN THE UNITED STATES

✍ Scribed by Gavaghan, M.; Abraham, J.; Pauer, L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHP95 Payer Perspectives on Evidence for

✍ A. Wang; T. Baerwaldt; R. Kuan; R. Nordyke; R. Halbert 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Orphan Disease Drug Costs In The United

✍ Davis, E.A.; Schwartz, E.L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

The impact of new (orphan) drug approval

✍ Lichtenberg, Frank R. 📂 Article 📅 2011 🏛 Springer 🌐 French ⚖ 326 KB

PHP48 THE EFFECTS OF NICE HTA'S ON PRESC

✍ B Sepulveda; N Horowicz-Mehler; JJ Doyle 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Antisocial behavioral syndromes and DSM-

✍ Risë B. Goldstein; Wilson M. Compton; Attila J. Pulay; W. June Ruan; Roger P. Pi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Comorbidity between DSM-IV alcohol and s

✍ Frederick S. Stinson; Bridget F. Grant; Deborah A. Dawson; W. June Ruan; Boji Hu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB